A detailed history of Federated Hermes, Inc. transactions in Journey Medical Corp stock. As of the latest transaction made, Federated Hermes, Inc. holds 853 shares of DERM stock, worth $4,401. This represents 0.0% of its overall portfolio holdings.

Number of Shares
853
Previous 1,329 35.82%
Holding current value
$4,401
Previous $7,000 42.86%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$4.22 - $5.91 $2,008 - $2,813
-476 Reduced 35.82%
853 $4,000
Q1 2024

May 14, 2024

BUY
$2.92 - $5.47 $1,448 - $2,713
496 Added 59.54%
1,329 $4,000
Q4 2023

Jan 31, 2024

BUY
$2.7 - $7.96 $2,249 - $6,630
833 New
833 $4,000

Others Institutions Holding DERM

About Journey Medical Corp


  • Ticker DERM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 11,596,500
  • Market Cap $59.8M
  • Description
  • Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...
More about DERM
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.